Healthcare giant Johnson & Johnson has confirmed that it would buy all of New York-based biopharmaceutical company’s shares for $132 apiece, boosting its presence in the market for neurological disorder treatments.
View in browser
Cyndx Insights | Logo | EC

THE LATEST NEWS ON MERGERS & ACQUISITIONS, CAPITAL MARKETS AND TECH TRENDS
    Johnson & Johnson 700

    PHOTO: JOHNSON & JOHNSON

    J&J to buy neurological drugmaker Intra-Cellular for $14.6B

    Healthcare giant Johnson & Johnson has confirmed that it would buy all of New York-based biopharmaceutical company’s shares for $132 apiece, boosting its presence in the market for neurological disorder treatments. Read here

      Blackstone mulls $4B-plus sale of Liftoff app

      The New York-based buyout firm is weighing strategic options, including a sale, for the California-based mobile app marketing provider that could value the platform at more than $4 billion. Read here

      PHOTO: VISTRIA

      blackstonesquare

      Clearwater Analytics to buy Enfusion for $1.5B

      The Boise-headquartered provider of investment accounting and reporting solutions for institutional investors has agreed to acquire the Chicago-based investment management platform in a cash-and-stock deal. Read here

      PHOTO: PATRICK RODRIGUEZ

      Clearwater Analytics Patrick Rodriguez 300

      GSK to buy US cancer biotech IDRx for $1.15B

      The British multinational pharmaceutical giant has agreed to acquire the Boston-based clinical-stage biopharmaceutical company in a move to gain new cancer medicines. Read here

      PHOTO: JIM LINWOOD

      GSK Jim Linwood 300

      DEALS ROUNDUP

      • Bain Capital ups bid for Insignia to $1.8B, matches CC Capital 
      • Kardigan raises $300M in Series A led by Perceptive Advisors 
      • Live shopping platform Whatnot rings up $265M in funding   
      • $19B AI provider CoreWeave opens first global data centers  
      • Hippocratic AI achieves unicorn status with $141M round 
      • AI healthcare startup Qventus nabs $105M at $400M valuation 
      • RhyGaze closes $86M Series A funding led by Google Ventures
      • Normunity secures $75M Series B for new anti-cancer therapy 
      • Leyden Labs gets $70M to protect against respiratory viruses 
      • Overhaul receives $55M funding led by Springcoast Partners

        INTERNATIONAL MARKETS

        Retailer EG Group eyes $13B New York IPO 

        The British gas station and convenience store company supported by private equity firm TDR Capital is preparing for an initial public offering. Read here

        Ownership Matters favors $5.8B Chemist-Sigma deal

        The Australian proxy advisory firm has recommended that shareholders of Sigma Healthcare vote in favor of Chemist Warehouse's reverse takeover of the company. Read here

        CATL poised to pick banks for $5B HK share sale  

        Contemporary Amperex Technology is set to hire Bank of America, China International Capital, CSC Financial, and JPMorgan Chase as lead arrangers for a second listing. Read here

          Abu Dhabi’s ADQ offers to buy Aramex at $1.2B value

          The sovereign fund, through its subsidiary Q Logistics, may take full control of the Dubai-based provider of comprehensive logistics and transportation solutions. Read here

            JOIN OUR FREE WEBINAR!

            AI-Driven Business Valuation

            JANUARY 22, 12:30 PM EST

            REGISTER HERE
            Cyndx-logo-Mark-White

            Join Our LinkedIn Community

            Questions? Please email us at marketing@cyndx.com. 

            Did a friend forward you this email? Subscribe here.

            Facebook
            LinkedIn
            X
            Instagram

            Cyndx Networks LLC, 525 Okeechobee Blvd. #840, West Palm Beach, Florida 33401

            Unsubscribe Manage preferences